ARCHIVES

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

This article is from The Cancer Letter archive.

Vol. 11 No. 31 | August 2, 1985

Download PDF Visit The Full Archive

Related Articles

Lung, Head & Neck Treatment Advances Reported At ASCO Annual Meeting

May 27, 1977

In Brief: Nobel Prize Awarded to Blobel for Research On Protein Signaling; Work Funded By NIH

October 15, 1999

State Cancer Incidence Report Published by NCI, CDC

November 22, 2002

Advisors tell NCI to rethink contracts for clinical trials cooperative group tissue banks

November 21, 2003

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010

ABMT Trials Unlikely To show Clean Benefit for Breast Cancer; Data Release Debated

March 12, 1999